Pancreatic Cancer Research

ResearcherArmy Medical UniversityActive in the last 2 years

Jie Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3879-0971; OpenAlex author ID A5115694812. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. USP10 promotes pancreatic ductal adenocarcinoma progression by attenuating FOXC1 protein degradation to activate the WNT signaling pathway. Co-author DOI 10.7150/ijbs.92278↗
  2. Up-regulation of p21WAF1/CIP1 by small activating RNA inhibits the in vitro and in vivo growth of pancreatic cancer cells. Co-author DOI 10.1177/030089161209800620↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaojun Wang · 1 shared paper, 2024 · strength 0.22
  2. LeiDa Zhang · 1 shared paper, 2024 · strength 0.22
  3. Baozhong Shan · 1 shared paper, 2012 · strength 0.03
  4. Zhiping Zhang · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.